|
RAD54B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.998000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.289500E-02 |
| Normal-vs-Stage2 |
2.061800E-01 |
| Normal-vs-Stage3 |
9.414300E-02 |
| Normal-vs-Stage4 |
6.815800E-02 |
| Stage1-vs-Stage2 |
8.195800E-01 |
| Stage1-vs-Stage3 |
9.767600E-01 |
| Stage1-vs-Stage4 |
6.403400E-01 |
| Stage2-vs-Stage3 |
8.657600E-01 |
| Stage2-vs-Stage4 |
6.361400E-01 |
| Stage3-vs-Stage4 |
6.890800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.239500E-02 |
| Normal-vs-AfricanAmerican |
1.457370E-01 |
| Normal-vs-Asian |
7.935000E-01 |
| Caucasian-vs-AfricanAmerican |
8.443200E-01 |
| Caucasian-vs-Asian |
1.342240E-01 |
| AfricanAmerican-vs-Asian |
2.607800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.929640E-01 |
| Normal-vs-Female |
2.258400E-02 |
| Male-vs-Female |
3.370400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.174400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.504180E-02 |
| Normal-vs-Age(61-80Yrs) |
1.526580E-01 |
| Normal-vs-Age(81-100Yrs) |
2.909400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.598600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.948200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.182400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.568800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.922200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.390600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.515800E-01 |
| Classical-VS-Follicular |
6.699800E-01 |
| Classical-VS-Other |
9.602600E-01 |
| Classical-VS-Normal |
5.519800E-02 |
| Tall-VS-Follicular |
7.082000E-01 |
| Tall-VS-Other |
9.953800E-01 |
| Tall-VS-Normal |
1.343220E-01 |
| Follicular-VS-Other |
7.541800E-01 |
| Follicular-VS-Normal |
2.125200E-01 |
| Other-VS-Normal |
3.835000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.026000E-02 |
| Normal-vs-N1 |
6.452600E-01 |
| N0-vs-N1 |
2.432000E-01 |
|
|
